- Wednesday, August 2, 2023
8:00 AM – 8:15 AM ET
Welcome
8:00 AM – 8:15 AM ET
Welcome
8:15 AM – 8:30 AM ET
1 - Session 1: Debate: Neoadjuvant vs Adjuvant Immunotherapy for Locally Advanced HER-2 Positive Upper Gastrointestinal Tract (UGI) Cancers - Neoadjuvant Immunotherapy
8:15 AM – 8:30 AM ET
Session 1: Debate: Neoadjuvant vs Adjuvant Immunotherapy for Locally Advanced HER-2 Positive Upper Gastrointestinal Tract (UGI) Cancers - Neoadjuvant ImmunotherapyPresenter: – Memorial Sloan Kettering Cancer Center
Yelena Y. Janjigian, MD – Memorial Sloan Kettering Cancer Center ### 1003985###Presenter###Chief, Gastrointestinal Oncology Service###Memorial Sloan Kettering Cancer Center###Presenter: – Memorial Sloan Kettering Cancer Center
### 8:30 AM – 8:45 AM ET
1 - Session 1: Debate: Neoadjuvant vs Adjuvant Immunotherapy for Locally Advanced HER-2 Positive Upper Gastrointestinal Tract (UGI) Cancers - Adjuvant Immunotherapy
8:30 AM – 8:45 AM ET
Session 1: Debate: Neoadjuvant vs Adjuvant Immunotherapy for Locally Advanced HER-2 Positive Upper Gastrointestinal Tract (UGI) Cancers - Adjuvant ImmunotherapyPresenter: – Kansas University Cancer Center
Anup Kasi, MD, MPH – Kansas University Cancer Center ### 1919511###Presenter###Associate Professor###Kansas University Cancer Center###Presenter: – Kansas University Cancer Center
### 8:45 AM – 9:00 AM ET
1 - Session 1: Debate: Neoadjuvant vs Adjuvant Immunotherapy for Locally Advanced HER-2 Positive Upper Gastrointestinal Tract (UGI) Cancers - Discussion
8:45 AM – 9:00 AM ET
Session 1: Debate: Neoadjuvant vs Adjuvant Immunotherapy for Locally Advanced HER-2 Positive Upper Gastrointestinal Tract (UGI) Cancers - DiscussionModerator: – Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center
Moderator: – Vanderbilt-Ingram Cancer Center
Panelist: – Memorial Sloan Kettering Cancer Center
Panelist: – Kansas University Cancer Center
Jordan D. Berlin, MD – Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center ### 697513###Moderator###Ingram Professor of Cancer Research###Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center###Moderator: – Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center
### @@@ Cathy Eng, MD, FACP, FASCO – Vanderbilt-Ingram Cancer Center ### 697457###Moderator###David H. Johnson Endowed Chair in Surgical and Medical Oncology, Co-Director, GI Oncology, Co-Leader, Gastrointestinal Cancer Research Program###Vanderbilt-Ingram Cancer Center###Moderator: – Vanderbilt-Ingram Cancer Center
### @@@ Yelena Y. Janjigian, MD – Memorial Sloan Kettering Cancer Center ### 1003985###Panelist###Chief, Gastrointestinal Oncology Service###Memorial Sloan Kettering Cancer Center###Panelist: – Memorial Sloan Kettering Cancer Center
### @@@ Anup Kasi, MD, MPH – Kansas University Cancer Center ### 1919511###Panelist###Associate Professor###Kansas University Cancer Center###Panelist: – Kansas University Cancer Center
### 9:00 AM – 9:15 AM ET
Break
9:00 AM – 9:15 AM ET
Break
9:15 AM – 10:00 AM ET
2 - Session 2: Special Topic on Gastric Cancer
9:15 AM – 10:00 AM ET
Session 2: Special Topic on Gastric Cancer
10:00 AM – 10:15 AM ET
Break
10:00 AM – 10:15 AM ET
Break
10:15 AM – 11:15 AM ET
Non-CME Innvoation Theater
10:15 AM – 11:15 AM ET
Non-CME Innovation Theater
11:15 AM – 11:30 AM ET
Break
11:15 AM – 11:30 AM ET
Break
11:30 AM – 11:45 AM ET
Session 3: Debate: Neoadjuvant Combined Immunotherapy vs Chemotherapy for MSI-H Locally Resectable Gastric or Gastroesophageal Junction Adenocarcinoma (GAC/GEJAC) - Neoadjuvant Combined Immunotherapy
11:30 AM – 11:45 AM ET
Session 3: Debate: Neoadjuvant Combined Immunotherapy vs Chemotherapy for MSI-H Locally Resectable Gastric or Gastroesophageal Junction Adenocarcinoma (GAC/GEJAC) - Neoadjuvant Combined ImmunotherapyPresenter: – Memorial Sloan Kettering Cancer Center
Yelena Y. Janjigian, MD – Memorial Sloan Kettering Cancer Center ### 1003985###Presenter###Chief, Gastrointestinal Oncology Service###Memorial Sloan Kettering Cancer Center###Presenter: – Memorial Sloan Kettering Cancer Center
### 11:45 AM – 12:00 PM ET
Session 3: Debate: Neoadjuvant Combined Immunotherapy vs Chemotherapy for MSI-H Locally Resectable Gastric or Gastroesophageal Junction Adenocarcinoma (GAC/GEJAC) - Chemotherapy
11:45 AM – 12:00 PM ET
Session 3: Debate: Neoadjuvant Combined Immunotherapy vs Chemotherapy for MSI-H Locally Resectable Gastric or Gastroesophageal Junction Adenocarcinoma (GAC/GEJAC) - ChemotherapyPresenter: – Kansas University Cancer Center
Anup Kasi, MD, MPH – Kansas University Cancer Center ### 1919511###Presenter###Associate Professor###Kansas University Cancer Center###Presenter: – Kansas University Cancer Center
### 12:00 PM – 12:15 PM ET
Session 3: Debate: Neoadjuvant Combined Immunotherapy vs Chemotherapy for MSI-H Locally Resectable Gastric or Gastroesophageal Junction Adenocarcinoma (GAC/GEJAC)
12:00 PM – 12:15 PM ET
Session 3: Debate: Neoadjuvant Combined Immunotherapy vs Chemotherapy for MSI-H Locally Resectable Gastric or Gastroesophageal Junction Adenocarcinoma (GAC/GEJAC) - DiscussionModerator: – Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center
Moderator: – Vanderbilt-Ingram Cancer Center
Panelist: – Kansas University Cancer Center
Panelist: – Memorial Sloan Kettering Cancer Center
Jordan D. Berlin, MD – Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center ### 697513###Moderator###Ingram Professor of Cancer Research###Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center###Moderator: – Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center
### @@@ Cathy Eng, MD, FACP, FASCO – Vanderbilt-Ingram Cancer Center ### 697457###Moderator###David H. Johnson Endowed Chair in Surgical and Medical Oncology, Co-Director, GI Oncology, Co-Leader, Gastrointestinal Cancer Research Program###Vanderbilt-Ingram Cancer Center###Moderator: – Vanderbilt-Ingram Cancer Center
### @@@ Anup Kasi, MD, MPH – Kansas University Cancer Center ### 1919511###Panelist###Associate Professor###Kansas University Cancer Center###Panelist: – Kansas University Cancer Center
### @@@ Yelena Y. Janjigian, MD – Memorial Sloan Kettering Cancer Center ### 1003985###Panelist###Chief, Gastrointestinal Oncology Service###Memorial Sloan Kettering Cancer Center###Panelist: – Memorial Sloan Kettering Cancer Center
### 12:15 PM – 12:30 PM ET
Break
12:15 PM – 12:30 PM ET
Break
12:30 PM – 1:15 PM ET
4 - Session 4: Special Topic on Genomic Testing
12:30 PM – 1:15 PM ET
Session 4: Special Topic on Genomic Testing
1:15 PM – 1:30 PM ET
Break
1:15 PM – 1:30 PM ET
Break
1:30 PM – 2:30 PM ET
Non-CME Innvoation Theater
1:30 PM – 2:30 PM ET
Non-CME Innovation Theater
2:30 PM – 2:45 PM ET
Break
2:30 PM – 2:45 PM ET
Break
2:45 PM – 3:30 PM ET
5 - Session 5: Special Topic on ctDNA
2:45 PM – 3:30 PM ET
Session 5: Special Topic on ctDNA
3:30 PM – 3:45 PM ET
Break
3:30 PM – 3:45 PM ET
Break
3:45 PM – 4:30 PM ET
6 - Session 6: Integration of Supportive Care
3:45 PM – 4:30 PM ET
Session 6: Integration of Supportive CarePresenter: –
Memorial Sloan Kettering Cancer Center
Andrew Epstein, MD –
Memorial Sloan Kettering Cancer Center ### 1880690###Presenter###Associate Attending ###
Memorial Sloan Kettering Cancer Center###Presenter: –
Memorial Sloan Kettering Cancer Center
### 4:30 PM – 4:45 PM ET
Break
4:30 PM – 4:45 PM ET
Break
4:45 PM – 5:30 PM ET
7 - Session 7: Perspectives on Clinical Trial Development in Anal Cancer
4:45 PM – 5:30 PM ET
Session 7: Perspectives on Clinical Trial Development in Anal CancerPresenter: – Vanderbilt-Ingram Cancer Center
Cathy Eng, MD, FACP, FASCO – Vanderbilt-Ingram Cancer Center ### 697457###Presenter###David H. Johnson Endowed Chair in Surgical and Medical Oncology, Co-Director, GI Oncology, Co-Leader, Gastrointestinal Cancer Research Program###Vanderbilt-Ingram Cancer Center###Presenter: – Vanderbilt-Ingram Cancer Center
###